Registry of transcatheter aortic valve replacement in Northeast China
Part of Heart & circulation clinical trials.
This study collects information from people in Northeast China who have severe aortic stenosis and are getting a TAVR procedure to replace their heart valve. The goal is to see how well the procedure works in real life, which may help improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have severe aortic stenosis, which means your heart valve is very narrowed and may cause symptoms like chest pain or shortness of breath.
- You must be planning to have or already have had a TAVR procedure to replace the valve via a catheter.
- You must be willing to sign a consent form and agree to follow-up visits or phone calls.
- You cannot be allergic to aspirin, heparin, clopidogrel, nickel-titanium alloy, or contrast dye.
- You cannot be pregnant or breastfeeding, and you cannot be in another drug or device study at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks patients with severe aortic stenosis who receive the Myval transcatheter heart valve during TAVR (a less-invasive valve replacement). It aims to understand how well the valve works over time.
This study looks at how safe and effective emergency aortic valve replacement is for people with severe aortic stenosis, a condition where the heart's main valve becomes narrow. It aims to help patients who are in critical condition, such as those in shock or with dangerous heart rhythms, by replacing the valve urgently.
This study records results of a minimally invasive procedure to replace a narrowed or leaking heart valve. It may help doctors understand how well the treatment works and what complications happen in Chinese patients.
This trial tests a new valve device placed through a small tube (catheter) to treat severe aortic stenosis, a condition where the aortic valve is narrowed and doesn't open fully. It's for patients who cannot have traditional open-heart surgery.
This trial tests a new type of aortic valve replacement that can be inserted without open-heart surgery. It's designed for people with severe aortic stenosis who are not suitable for a standard operation.
This study is for people with a severe leaking aortic valve (aortic regurgitation) who are too high-risk for open-heart surgery. It tracks how well a less-invasive valve replacement (TAVI) using the JenaValve or J-Valve works for them.
Hear when a new Severe Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.